Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Acute Myeloid Leukemia: Nanomedicine drug delivery system could improve chemotherapy

18.12.2012
Chemotherapy is still the backbone of today’s cancer treatment. This is exemplified by acute myeloid leukemia (AML), a disease which is responsive to intense chemotherapy based treatment regimens, which are at least curative in a fraction of patients. Anthracyclines belong to the key chemotherapeutic drugs applied worldwide in the treatment of AML.
Unfortunately, the administration dose of anthracyclines is limited by their cardiotoxicity and the development of drug-resistance of tumors. In addition, the efficiency of anthracyclines decreases during circulation in the blood stream due to its rapid metabolicdegradation.

To improve the pharmacological properties of anthracyclines, a novel nanomedicine drug delivery system has been developed by the groups of Prof. Dr. Tanja Weil (Institute of Organic Chemistry/Macromolecular Chemistry, Ulm University) and Prof. Dr. Christian Buske (Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm).

This biopolymer carries multiple copies of an anti-tumor drug molecule, it shows high stability in serum and efficient release in tumor cells by a dual mechanism. Significantly higher survival rates have been observed in an ex vivo animal model suggesting its potential for designing next generation anti-leukemia treatments. The results have been published in the Journal of Advanced Healthcare Materials.

Yuzhou Wu, Susann Ihme, Michaela Feuring-Buske, Seah Ling Kuan, Klaus Eisele, Markus Lamla, Yanran Wang, Christian Buske, and Tanja Weil. A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity. Advanced Healthcare Materials. http://doi.wiley.com/10.1002/adhm.201200296.”

Further information:
Prof. Dr. Tanja Weil, Tel.: 0049/731 50-22871 or 0049/731 50-22870
Prof. Dr. Christian Buske, Tel.: 0049/731 500-65800
PD Dr. Michaela Feuring-Buske, Tel.: 0049/731 500-65823

Willi Baur | idw
Further information:
http://www.uni-ulm.de/
http://doi.wiley.com/10.1002/adhm.201200296

More articles from Life Sciences:

nachricht Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)

nachricht CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>